Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05212363 · ClinicalTrials.gov registry record · NA
Lower Leg Compression in Extended Video Game Play: A Pilot Study
A NA study, sponsored by New York Institute of Technology.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05212363: Clinical Trial NA study, sponsored by New York Institute of Technology.
NCT05212363 is a NA study that was terminated before completion, run by New York Institute of Technology. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05212363, a NA study, was terminated before completion, sponsored by New York Institute of Technology.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Compression garments are used to exert external pressure on the lower extremities to reduce vascular wall tension and prevent gravity form pooling blood in the lower extremities which will improve venous return and lymphatic output. Given the nature of video game play, sitting for prolonged periods of time without an active break is the perfect scenario to put these players at risk for deep vein thromboses (DVTs). Graduated compression wear may offer significant health benefits to this rapidly expanding sport. This study is essential to the formation of effective performance wear to reduce health risks in a gaming population.
Primary Outcome
A B0MJ18Philips L9-3 Transducer will be used to measure popliteal artery blood velocity at rest, and every 30 minutes for 120 minutes during prolonged gaming
Interventions
- DEVICE Lower extremity compression garments
- BEHAVIORAL Active break
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2022-04-02 |
| Phase | NA |
Why NCT05212363 stopped before completion
NCT05212363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Lower extremity compression garments is the first listed.
NCT05212363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05212363 about?
NCT05212363 is a clinical study titled "Lower Leg Compression in Extended Video Game Play: A Pilot Study". Compression garments are used to exert external pressure on the lower extremities to reduce vascular wall tension and prevent gravity form pooling blood in the lower extremities which will improve venous return and lymphatic output. Given the nature of video game play, sitting for prolonged periods ...
What is the current status of trial NCT05212363?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-12-09. Estimated completion is 2022-04-02.
What interventions are being tested in trial NCT05212363?
The interventions under investigation include: Lower extremity compression garments (DEVICE), Active break (BEHAVIORAL).
Who is sponsoring clinical trial NCT05212363?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05212363's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI